Biotech

Crispr For All
A Gene-Editing Therapy Cut Cholesterol Levels by Half
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Designer babies
A New Startup Wants to Edit Human Embryos

Intellectual Property
Neuralink’s Bid to Trademark ‘Telepathy’ and ‘Telekinesis’ Faces Legal Issues

Thinking Ahead
















